Cargando…
The effect of sulindac, a non-steroidal anti-inflammatory drug, attenuates inflammation and fibrosis in a mouse model of chronic pancreatitis
BACKGROUND: Chronic pancreatitis is characterized by progressive fibrosis, pain and loss of exocrine and endocrine functions. The long-standing chronic pancreatitis and its associated pancreatic fibrosis are the most common pathogenic events involved in human pancreatic carcinogenesis, but the thera...
Autores principales: | Bai, Han, Chen, Xiaokai, Zhang, Lin, Dou, Xiaoguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503779/ https://www.ncbi.nlm.nih.gov/pubmed/22920325 http://dx.doi.org/10.1186/1471-230X-12-115 |
Ejemplares similares
-
Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator
por: Yin, Tao, et al.
Publicado: (2016) -
New use for an old drug: COX‐independent anti‐inflammatory effects of sulindac in models of cystic fibrosis
por: Rocca, Jérémy, et al.
Publicado: (2016) -
Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
por: Davis, Jennifer S., et al.
Publicado: (2020) -
Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate
por: MURRAY, ONIKA T., et al.
Publicado: (2013) -
Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)